New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - dobutamine hydrochloride 56.05mg equivalent to dobutamine 50 mg - concentrate for infusion - 50 mg/ml - active: dobutamine hydrochloride 56.05mg equivalent to dobutamine 50 mg excipient: ascorbic acid water for injection - dobutamine hydrochloride is indicated when inotropic support is necessary for the treatment of patients with hypoperfusion states in whom cardiac output is insufficient to meet circulatory demands. dobutamine hydrochloride is also indicated when inotropic support is required for the treatment of patients in whom abnormally increased ventricular filling pressures introduce the risk of pulmonary congestion and oedema. conditions which may precipitate such situations include the following hypoperfusion states: initially cardiac in origin a. acute heart failure 1. acute myocardial infarction 2. cardiogenic shock 3. following cardiac surgery 4. medicine-induced depression of cardiac contractility such as that which occurs in excessive beta-adrenergic receptor blockade. b. chronic heart failure 1. acute decompensation of chronic congestive heart failure 2. temporary inotropic support in advanced chronic congestive heart failure, as an adjunct to therapy with conventional oral inotropic agents, systemic vasodilators, and diuretics. initially non-cardiac in origin 1. acute hypoperfusion states secondary to trauma, surgery, sepsis, or hypovolaemia when mean arterial pressure is above 70-mm hg and pulmonary capillary wedge pressure is 18-mm hg or greater, with inadequate response to volume repletion and increased ventricular filling pressure 2. low cardiac output secondary to mechanical ventilation with positive end-expiratory pressure (peep). dobutamine hydrochloride may be used as a substitute for physical exercise in stress testing in the diagnosis of coronary artery disease. when dobutamine hydrochloride is used for this purpose, as is the case when exercise is used for stress testing, patients should be informed of the potential risks involved in the test. in addition, patients should be subjected to the same close monitoring that is mandatory in standard exercise stress tests, including continuous electrocardiographic monitoring.

Nigeria - English - NAFDAC (National Agency for Food and Drugs Administration and Control)

dobutamine hcl 280.3mg

Egypt - English - EDA (Egyptian Drug Authority)

amc - injection - 50 mg/ml

Singapore - English - HSA (Health Sciences Authority)

m.b.d. marketing (s) pte ltd - dobutamine hcl eqv dobutamine - injection - 50.0mg - dobutamine hcl eqv dobutamine 50 mg/ml

Bahrain - English - الهيئة الوطنية لتنظيم المهن والخدمات الصحية، مملكة البحرين

jaffar pharmacy - dobutamine hydrochloride - iv infusion - 250

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

bayer oy - dobutamine - solution for injection - 50 mg/ml

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

primex pharmaceuticals oy, finland - dobutamine - concentrate for peritoneal dialysis solution - 50 mg/ml

Jordan - English - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

شركة مستودع الأدوية الأردني - the jordan drugstore co - dobutamine 250 mg/5ml - 250 mg/5ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

base) 4mg/4ml concentrate for solution for infusion ampoules (pfizer ltd - noradrenaline acid tartrate - solution for infusion - 1mg/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

base) 4mg/4ml concentrate for solution for infusion ampoules (aguettant ltd - noradrenaline acid tartrate - solution for infusion - 1mg/1ml